Awaiting product image

RDL F

Used In Mixed Dyslipidemia

Rosuvastatin inhibits HMG-CoA reductase (rate-limiting enzyme in cholesterol biosynthesis). Fenofibrate activates PPAR-α (Peroxisome Proliferator-Activated Receptor alpha) and reduces TG levels significantly.

Category: Tag:

Description

Rosuvastatin 10mg+ Fenofibrate 160mg

Used In Mixed Dyslipidemia

Combination targets atherogenic dyslipidemia (↑ TG, ↓ HDL-C, moderately ↑ LDL-C), commonly seen in diabetes & metabolic syndrome.

Dosage:Available in oral tablet form. Once Daily

Related Products